SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001273636-20-000017
Filing Date
2020-12-18
Accepted
2020-12-18 17:50:12
Documents
2
Period of Report
2020-12-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3866
2 VANLENT POWER OF ATTORNEY attachment_1.htm EX-24 2242
  Complete submission text file 0001273636-20-000017.txt   7544
Mailing Address C/O BARRIER THERAPEUTICS, INC. 600 COLLEGE ROAD EAST, SUITE 3200 PRINCETON NJ 08540
Business Address
VANLENT ANNE (Reporting) CIK: 0001229243 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36370 | Film No.: 201401770

Mailing Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615
Business Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615 386-462-2204
APPLIED GENETIC TECHNOLOGIES CORP (Issuer) CIK: 0001273636 (see all company filings)

IRS No.: 593553710 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)